Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
English Section

Polish firm to produce COVID-19 vaccine

03.03.2021 12:30
Polish biotechnology firm Mabion has struck a deal with US drug maker Novavax to produce a COVID-19 vaccine, officials announced on Wednesday.
Photo:Hakan Nural/Anadolu Agency/PAP/ABACAPRESS.COM

The Polish Development Fund (PFR), a state-run investment vehicle, will help finance the project, its CEO Paweł Borys told the media.

Paweł Borys Paweł Borys. Photo: Polish Radio

He added that as a result Poland would join the group of countries where COVID-19 vaccines are produced.

Mabion said it had clinched a deal with Novavax for the transfer of know-how in the second quarter of this year and for technology tests to produce an antigen for a COVID-19 vaccine candidate.

The company added that it had also signed an agreement with the Polish Development Fund under which the latter would invest up to PLN 40 million (EUR 8.8 million, USD 10.6 million) to increase Mabion’s production capacity.

A Novavax vaccine is currently in the process of being registered by the European Medicines Agency, the EU's drug regulator, Poland’s PAP news agency reported.


Source: PAP, mabion.eu

Click on the ‘Play' button above for an audio report